 | • レポートコード：GIR-107A12191 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、Cox-2阻害薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。Cox-2阻害薬の種類別市場規模（選択的Cox-2阻害薬、非選択的Cox-2阻害薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・Cox-2阻害薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Novartis、Pfizer、Merck、Cadila Pharmaceuticals、Sabinsa Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：選択的Cox-2阻害薬、非選択的Cox-2阻害薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・Cox-2阻害薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・Cox-2阻害薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・Cox-2阻害薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・Cox-2阻害薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・Cox-2阻害薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cox-2 Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cox-2 Inhibitors size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cox-2 Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cox-2 Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cox-2 Inhibitors
1.2 Classification of Cox-2 Inhibitors by Type
1.2.1 Overview: Global Cox-2 Inhibitors Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cox-2 Inhibitors Revenue Market Share by Type in 2020
1.2.3 Selective Cox-2 Inhibitors
1.2.4 Non Selective Cox-2 Inhibitors
1.3 Global Cox-2 Inhibitors Market by Application
1.3.1 Overview: Global Cox-2 Inhibitors Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Cox-2 Inhibitors Market Size & Forecast
1.5 Global Cox-2 Inhibitors Market Size and Forecast by Region
1.5.1 Global Cox-2 Inhibitors Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cox-2 Inhibitors Market Size by Region, (2016-2021)
1.5.3 North America Cox-2 Inhibitors Market Size and Prospect (2016-2026)
1.5.4 Europe Cox-2 Inhibitors Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cox-2 Inhibitors Market Size and Prospect (2016-2026)
1.5.6 South America Cox-2 Inhibitors Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cox-2 Inhibitors Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cox-2 Inhibitors Market Drivers
1.6.2 Cox-2 Inhibitors Market Restraints
1.6.3 Cox-2 Inhibitors Trends Analysis
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Cox-2 Inhibitors Product and Solutions
2.1.4 Bayer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cox-2 Inhibitors Product and Solutions
2.2.4 Novartis Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Cox-2 Inhibitors Product and Solutions
2.3.4 Pfizer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Cox-2 Inhibitors Product and Solutions
2.4.4 Merck Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Cadila Pharmaceuticals
2.5.1 Cadila Pharmaceuticals Details
2.5.2 Cadila Pharmaceuticals Major Business
2.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Product and Solutions
2.5.4 Cadila Pharmaceuticals Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cadila Pharmaceuticals Recent Developments and Future Plans
2.6 Sabinsa Corporation
2.6.1 Sabinsa Corporation Details
2.6.2 Sabinsa Corporation Major Business
2.6.3 Sabinsa Corporation Cox-2 Inhibitors Product and Solutions
2.6.4 Sabinsa Corporation Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sabinsa Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cox-2 Inhibitors Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cox-2 Inhibitors Players Market Share
3.2.2 Top 10 Cox-2 Inhibitors Players Market Share
3.2.3 Market Competition Trend
3.3 Cox-2 Inhibitors Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cox-2 Inhibitors Revenue and Market Share by Type (2016-2021)
4.2 Global Cox-2 Inhibitors Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cox-2 Inhibitors Revenue Market Share by Application (2016-2021)
5.2 Cox-2 Inhibitors Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cox-2 Inhibitors Revenue by Type (2016-2026)
6.2 North America Cox-2 Inhibitors Revenue by Application (2016-2026)
6.3 North America Cox-2 Inhibitors Market Size by Country
6.3.1 North America Cox-2 Inhibitors Revenue by Country (2016-2026)
6.3.2 United States Cox-2 Inhibitors Market Size and Forecast (2016-2026)
6.3.3 Canada Cox-2 Inhibitors Market Size and Forecast (2016-2026)
6.3.4 Mexico Cox-2 Inhibitors Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cox-2 Inhibitors Revenue by Type (2016-2026)
7.2 Europe Cox-2 Inhibitors Revenue by Application (2016-2026)
7.3 Europe Cox-2 Inhibitors Market Size by Country
7.3.1 Europe Cox-2 Inhibitors Revenue by Country (2016-2026)
7.3.2 Germany Cox-2 Inhibitors Market Size and Forecast (2016-2026)
7.3.3 France Cox-2 Inhibitors Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cox-2 Inhibitors Market Size and Forecast (2016-2026)
7.3.5 Russia Cox-2 Inhibitors Market Size and Forecast (2016-2026)
7.3.6 Italy Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cox-2 Inhibitors Revenue by Type (2016-2026)
8.2 Asia-Pacific Cox-2 Inhibitors Revenue by Application (2016-2026)
8.3 Asia-Pacific Cox-2 Inhibitors Market Size by Region
8.3.1 Asia-Pacific Cox-2 Inhibitors Revenue by Region (2016-2026)
8.3.2 China Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8.3.3 Japan Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8.3.4 South Korea Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8.3.5 India Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cox-2 Inhibitors Market Size and Forecast (2016-2026)
8.3.7 Australia Cox-2 Inhibitors Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cox-2 Inhibitors Revenue by Type (2016-2026)
9.2 South America Cox-2 Inhibitors Revenue by Application (2016-2026)
9.3 South America Cox-2 Inhibitors Market Size by Country
9.3.1 South America Cox-2 Inhibitors Revenue by Country (2016-2026)
9.3.2 Brazil Cox-2 Inhibitors Market Size and Forecast (2016-2026)
9.3.3 Argentina Cox-2 Inhibitors Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cox-2 Inhibitors Revenue by Type (2016-2026)
10.2 Middle East & Africa Cox-2 Inhibitors Revenue by Application (2016-2026)
10.3 Middle East & Africa Cox-2 Inhibitors Market Size by Country
10.3.1 Middle East & Africa Cox-2 Inhibitors Revenue by Country (2016-2026)
10.3.2 Turkey Cox-2 Inhibitors Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cox-2 Inhibitors Market Size and Forecast (2016-2026)
10.3.4 UAE Cox-2 Inhibitors Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cox-2 Inhibitors Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cox-2 Inhibitors Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cox-2 Inhibitors Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cox-2 Inhibitors Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cox-2 Inhibitors Revenue Market Share by Region (2021-2026)
Table 6. Bayer Corporate Information, Head Office, and Major Competitors
Table 7. Bayer Major Business
Table 8. Bayer Cox-2 Inhibitors Product and Solutions
Table 9. Bayer Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Cox-2 Inhibitors Product and Solutions
Table 13. Novartis Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Cox-2 Inhibitors Product and Solutions
Table 17. Pfizer Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Cox-2 Inhibitors Product and Solutions
Table 21. Merck Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Cadila Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Cadila Pharmaceuticals Major Business
Table 24. Cadila Pharmaceuticals Cox-2 Inhibitors Product and Solutions
Table 25. Cadila Pharmaceuticals Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sabinsa Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Sabinsa Corporation Major Business
Table 28. Sabinsa Corporation Cox-2 Inhibitors Product and Solutions
Table 29. Sabinsa Corporation Cox-2 Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Cox-2 Inhibitors Revenue (USD Million) by Players (2019-2021)
Table 31. Global Cox-2 Inhibitors Revenue Share by Players (2019-2021)
Table 32. Breakdown of Cox-2 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Cox-2 Inhibitors Players Head Office, Products and Services Provided
Table 34. Cox-2 Inhibitors Mergers & Acquisitions in the Past Five Years
Table 35. Cox-2 Inhibitors New Entrants and Expansion Plans
Table 36. Global Cox-2 Inhibitors Revenue (USD Million) by Type (2016-2021)
Table 37. Global Cox-2 Inhibitors Revenue Share by Type (2016-2021)
Table 38. Global Cox-2 Inhibitors Revenue Forecast by Type (2021-2026)
Table 39. Global Cox-2 Inhibitors Revenue by Application (2016-2021)
Table 40. Global Cox-2 Inhibitors Revenue Forecast by Application (2021-2026)
Table 41. North America Cox-2 Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Cox-2 Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Cox-2 Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Cox-2 Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Cox-2 Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Cox-2 Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Cox-2 Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Cox-2 Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Cox-2 Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Cox-2 Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Cox-2 Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Cox-2 Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Cox-2 Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Cox-2 Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Cox-2 Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Cox-2 Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Cox-2 Inhibitors Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Cox-2 Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Cox-2 Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Cox-2 Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Cox-2 Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Cox-2 Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Cox-2 Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Cox-2 Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Cox-2 Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Cox-2 Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Cox-2 Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Cox-2 Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Cox-2 Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Cox-2 Inhibitors Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cox-2 Inhibitors Picture
Figure 2. Global Cox-2 Inhibitors Revenue Market Share by Type in 2020
Figure 3. Selective Cox-2 Inhibitors
Figure 4. Non Selective Cox-2 Inhibitors
Figure 5. Cox-2 Inhibitors Revenue Market Share by Application in 2020
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Global Cox-2 Inhibitors Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Cox-2 Inhibitors Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Cox-2 Inhibitors Revenue Market Share by Region (2016-2026)
Figure 12. Global Cox-2 Inhibitors Revenue Market Share by Region in 2020
Figure 13. North America Cox-2 Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Cox-2 Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Cox-2 Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Cox-2 Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Cox-2 Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Cox-2 Inhibitors Market Drivers
Figure 19. Cox-2 Inhibitors Market Restraints
Figure 20. Cox-2 Inhibitors Market Trends
Figure 21. Bayer Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Cadila Pharmaceuticals Recent Developments and Future Plans
Figure 26. Sabinsa Corporation Recent Developments and Future Plans
Figure 27. Global Cox-2 Inhibitors Revenue Share by Players in 2020
Figure 28. Cox-2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Cox-2 Inhibitors Revenue Market Share in 2020
Figure 30. Global Top 10 Players Cox-2 Inhibitors Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Cox-2 Inhibitors Revenue Share by Type in 2020
Figure 33. Global Cox-2 Inhibitors Market Share Forecast by Type (2021-2026)
Figure 34. Global Cox-2 Inhibitors Revenue Share by Application in 2020
Figure 35. Global Cox-2 Inhibitors Market Share Forecast by Application (2021-2026)
Figure 36. North America Cox-2 Inhibitors Sales Market Share by Type (2016-2026)
Figure 37. North America Cox-2 Inhibitors Sales Market Share by Application (2016-2026)
Figure 38. North America Cox-2 Inhibitors Revenue Market Share by Country (2016-2026)
Figure 39. United States Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Cox-2 Inhibitors Sales Market Share by Type (2016-2026)
Figure 43. Europe Cox-2 Inhibitors Sales Market Share by Application (2016-2026)
Figure 44. Europe Cox-2 Inhibitors Revenue Market Share by Country (2016-2026)
Figure 45. Germany Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Cox-2 Inhibitors Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Cox-2 Inhibitors Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Cox-2 Inhibitors Revenue Market Share by Region (2016-2026)
Figure 53. China Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Cox-2 Inhibitors Sales Market Share by Type (2016-2026)
Figure 60. South America Cox-2 Inhibitors Sales Market Share by Application (2016-2026)
Figure 61. South America Cox-2 Inhibitors Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Cox-2 Inhibitors Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Cox-2 Inhibitors Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Cox-2 Inhibitors Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Cox-2 Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界のNSCLC用標的薬VEGFR2阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug VEGFR2 Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のホスホジエステラーゼ（PDE）阻害剤市場 2021：企業別、地域別、種類・用途別 The Phosphodiesterase (PDE) inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の多発性骨髄腫用プロテアソーム阻害剤市場 2021：企業別、地域別、種類・用途別 The Proteasome Inhibitors for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界のNSCLC用標的薬BRAF阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug BRAF Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…